← FDA DRUG APPROVALS
FDA ANDA · ANDA211295
CLOBETASOL PROPIONATE
clobetasol propionate ointment usp, 0.05%
Sponsor: ENCUBE
APPLICATION
ANDA211295
TYPE
ANDA
ORIGINAL APPROVAL
2019-11-15
LATEST ACTION
2019-11-15
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
CLOBETASOL PROPIONATEPrescription
CLOBETASOL PROPIONATE 0.05% · OINTMENT · TOPICAL
Approval history
2019-11-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.